Information content of five nomograms for outcomes in prostate cancer

American Journal of Clinical Pathology

Volumn 128, Issue 5, 2007, Pages 803-807

  Bismar, Tarek A ^a   Humphrey, Peter ^b   Vollmer, Robin T ^c,d  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Entropy; Gleason grade; Information; Needle cores; Nomogram; Prostate cancer; Prostate specific antigen; PSA; Stage; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENTROPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NOMOGRAM; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER;

ADENOCARCINOMA; ADULT; AGED; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 36248961145     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/XA419Q75F5D2TVJN     Document Type: Article

References (15)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Ross PL, Scardino PT, Kattan MW. A catalog of prostate cancer nomograms. J Urol. 2001;165:1562-1568.
3. Giasu S. Information Theory With Applications. New York, NY: McGraw-Hill; 1977.
4. Vollmer RT. Entropy and information content of laboratory test results. Am J Clin Pathol. 2007;127:60-65.
5. Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA. 1997;277:1445-1452
6. Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA. 1999;281:1598-1604.
7. D'Amico AV, Whittington R, Malkowicz SB, et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol. 1999;17:168-172.
8. Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006;98:715-717.
9. Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2002;20:3206-3212.
10. Greene KL, Meng MV, Elkin EP, et al. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (CaPSURE). J Urol. 2004;171:2255-2259.
11. Kattan MW, Eastham JA, Stapleton AMF, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst. 1998;90:766-771.
12. Gerber GS, Thisted RA, Scardino PT, et al. Results of radical prostatectomy in men with clinically localized prostate cancer: multi-institutional pooled analysis. JAMA. 1996;276:615-619.
13. Krongrad A, Lai H, Lai S. Survival after radical prostatectomy. JAMA. 1997;278:44-46.
14. Dillioglogil O, Leibman BD, Kattan MW, et al. Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology. 1997;50:93-99.
15. Pound CR, Partin AW, Epstein JI, et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Urol Clin North Am. 1997;24:395-406.